CA
SBIO icon

Cetera Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Cetera Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-451
Closed -$17K – 1220
2019
Q1 		$17K Buy
+451
New +$15.1K ﹤0.01% 1093

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return

Cetera Advisors's SBIO Position: Q2 2019 in Review

Cetera Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2019, closing a stake of 451 shares — an estimated $17K sold.

Cetera Advisors first reported a position in SBIO in Q1 2019 and held it in 1 quarter. The position peaked at $17K in Q1 2019. 47 funds tracked by Wall St. Rank hold SBIO as of Q2 2019.

  • Cetera Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2019 after selling out during the quarter.
  • Cetera Advisors sold 451 ALPS Medical Breakthroughs ETF shares in Q2 2019, an estimated $17K.
  • Cetera Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q1 2019 and held it in 1 quarter.
  • Cetera Advisors's ALPS Medical Breakthroughs ETF position peaked at $17K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2019.

Based on Cetera Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.